Cantor Fitzgerald

Cantor Fitzgerald is a leading global financial services firm founded in 1945 that specializes primarily in institutional equity/fixed-income sales/trading and investment banking. While it does not itself develop drugs or medical products—and thus has no therapeutic pipeline—it plays an influential role within the life sciences sector through its dedicated healthcare/bio-pharma investment banking franchise and highly regarded equity research teams covering biotechnology/pharmaceutical companies. The firm regularly hosts major industry conferences such as its annual Global Healthcare Conference attended by key opinion leaders from top biopharma firms like Pfizer and Regeneron. Recent expansions have further strengthened its presence across all verticals of healthcare services M&A/equity advisory. However, it should be noted that while deeply involved financially/advisorily within health-related industries—including providing market analysis on trends such as biotech sector performance—it remains fundamentally a financial institution rather than a health science company itself.